Frontline Treatment of Kidney Cancer With Pazopanib and Sunitinib

Special Reports, Genitourinary Cancers, Volume 1, Issue 1

James J. Hsieh, MD, PhD, medical oncologist, Memorial Sloan-Kettering Cancer Center, discusses the frontline treatment of patients with kidney cancer with pazopanib and sunitinib.

James J. Hsieh, MD, PhD, medical oncologist, Memorial Sloan-Kettering Cancer Center, discusses the frontline treatment of patients with kidney cancer with pazopanib and sunitinib.

The development of drugs that target angiogenesis and signal transduction pathways in the treatment of metastatic renal cell carcinoma has led to improved survival rates for patients.Read more > >